Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Al Gore and David Blood’s Generation Investment Fund Boosts Its Stake in $HSIC

David Blood and Al Gore’s Generation Investment Management boosted its stake in Henry Schein,Inc (HSIC) to 5.11% in mid June. Generation Investment had 4,454,610 shares of HSIC in its portfolio at the end of March. The fund currently holds 4.7 Million shares of the company.  The stock closed at $73.29 on Monday, July 11th.

David Blood

Generation Investment Management is the largest shareholder in HSIC with a $345 Million position. There are other hedge funds in HSIC as well. Ricky Sandler’s Eminence Capital and Robert Joseph Caruso’s Select Equity Group have large positions in Henry Schein. Clint Carlson’s Carlson Capital started a brand new position in HSIC during the first quarter.

Generation Investment Management (GIM) was co-founded in 2004 by David Blood and Al Gore. The fund is a long-only equity fund with a long-term focus. GIM targets liberals and left-leaning investors who are more sensitive about environment, ethics, labor unions, etc. That’s why they invest in only those companies that are socially and environmentally responsible, and have good corporate governance policies. Generation Global Equity Fund has $6 Billion in assets under management in early 2011 and is said to return more than 50% during the 12 months ending in March 2010. David Blood was formerly the chief executive of Goldman Sachs Asset Management. Former Vice President Al Gore works one day a week for the fund.

According to Google Finance; “Henry Schein, Inc. is a distributor of healthcare products and services primarily to office-based healthcare practitioners. It serves 700,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions. It conducts business in two segments: healthcare distribution and technology. These segments offer different products and services to the same customer base. The healthcare distribution segment aggregates dental, medical, animal health and international operating segments. The technology group provides software, technology and other value-added services to healthcare practitioners, primarily in the United States, Canada, the United Kingdom, Australia and New Zealand. On December 31, 2009, it acquired a majority interest in Butler Animal Health Holding Company, LLC. In April 2011, it acquired Alpha Scientific, Inc. In May 2011, it acquired Sogim Grimouille.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!